🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Minhee Kang

Harvard University

ORCID: 0000-0003-0150-2419

Also affiliated with Jangan University, Cancer Research And Biostatistics

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings”.

Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings

JAIDS Journal of Acquired Immune Deficiency Syndromes(2023)10.1097/qai.0000000000003236
N/A
0.645DataRank · unranked
15 citations

Di Chang, Jeannette Y. Lee, Larry Magpantay, Margaret Borok, Aggrey Bukuru +16 more

Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus

Clinical Infectious Diseases(2023)10.1093/cid/ciad201
N/A
0DataRank · unranked
35 citations

Minhee Kang, Triin Umbleja, Anchalee Avihingsanon, Patcharaphan Sugandhavesa, Andrea L. Cox +25 more

Design and analysis considerations for early phase clinical trials in hepatitis B (HBV) cure research: the ACTG A5394 study in persons with both HIV and HBV

Journal of Virus Eradication(2023)10.1016/j.jve.2023.100344
N/A
0DataRank · unranked
4 citations

Jennifer C. Price, Marion G. Peters, Sharon R. Lewin, Mark Sulkowski, Minhee Kang

Adverse Impact of HIV-1 on Long-term Outcomes Following HCV DAA Treatment: Final Results of ACTG A5320, the Viral Hepatitis C Infection Long-term Cohort Study (VHICS)

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad115
N/A
0DataRank · unranked
3 citations

Minhee Kang, Roy M. Matining, Robert L Murphy, Marion G. Peters, David Wyles

Mortality and Associated Risk Factors Among People Living With HIV With Kaposi Sarcoma: A5263/AMC066 and A5264/AMC067

JAIDS Journal of Acquired Immune Deficiency Syndromes(2024)10.1097/qai.0000000000003484
N/A
0DataRank · unranked
0 citations

Carlee Moser, Minhee Kang, Triin Umbleja, Michael D. Hughes, Thomas Campbell +14 more

An efficient vaccine clinical trial: ACTG A5379 hepatitis B vaccine trial in persons with HIV

Vaccine(2025)10.1016/j.vaccine.2025.127028
N/A
0DataRank · unranked
0 citations

Kristen Marks, Andrea L. Cox, Kenneth E. Sherman, Minhee Kang

Brief Report: Hepatitis B Vaccination Histories in Persons With HIV Needing Revaccination

JAIDS Journal of Acquired Immune Deficiency Syndromes(2025)10.1097/qai.0000000000003828
N/A
0DataRank · unranked
0 citations

Triin Umbleja, Anchalee Avihingsanon, Sandra Wagner Cardoso, Josphat Kosgei, Karen J. Vigil +6 more

Continued Low Rates of Hepatitis C Virus (HCV) Recurrence in HCV/HIV- and HCV-Infected Participants Who Achieved Sustained Virologic Response After Direct-Acting Antiviral Treatment: Final Results From the AIDS Clinical Trials Group A5320 Viral Hepatitis C Infection Long-term Cohort Study (V-HICS)

Open Forum Infectious Diseases(2021)10.1093/ofid/ofab511
N/A
0DataRank · unranked
2 citations

Minhee Kang, Roy M. Matining, Robert L Murphy, Marion G. Peters, David Wyles

Evaluation of Liver Fibrosis Change After DAA-induced Cure of Hepatitis C in Participants With and Without HIV: ACTG A5320 Viral Hepatitis C Infection Long-term Cohort Study (VHICS)

Open Forum Infectious Diseases(2025)10.1093/ofid/ofaf804
N/A
0DataRank · unranked
0 citations

Minhee Kang, R L Murphy, William Rosenberg, David L Wyles, Marion G Peters